Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI of Telmisartan, Amlodipine, and Chlorthalidone in Healthy Volunteers
NCT02152969Phase 1Completed
- Sponsor
- Yuhan
- Start
- May 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of telmisartan, amlodipine and chlorthalidone in hypertension (HTN) (2 arms), sponsored by Yuhan. Primary endpoints: Area Under the Curve at steady state at 24 hours and Maximum Plasma Concentration at steady state at 24 hours. Started May 2014; status: completed.
02
Drugs
telmisartanamlodipinechlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02152969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02152969.